
南美洲和中美洲测序试剂市场预测至 2028 年 - COVID-19 影响和区域分析(按技术(下一代测序、桑格测序和第三代测序)、应用(农业基因组学和法医学、临床调查、肿瘤学、生殖健康等)应用)、试剂类型(对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型)和最终用户(医院和诊所、研究机构、制药和生物技术公司和其他最终用户)
No. of Pages: 143 | Report Code: TIPRE00022832 | Category: Life Sciences
No. of Pages: 143 | Report Code: TIPRE00022832 | Category: Life Sciences
测序过程中会用到测序试剂。这些试剂的使用很大程度上取决于要获得的所需结果。它们构成了测序反应的重要组成部分,也可用于各种其他应用。
测序是测序反应的重要组成部分,也可用于各种其他应用。现在,测序试剂越来越多地用于临床实践,在未来五年内,预计将在医疗保健领域生成来自超过 6000 万患者的基因组数据。基因组测序正在迅速转变为临床实践,医疗保健系统的实施得到了政府大量投资的支持,至少 14 个国家的投资总额超过 40 亿美元。这些国家基因组医学计划正在推动现实生活中的变革,同时解决实施障碍并收集证据以供更广泛采用,从而推动测序试剂市场的增长。此外,制造商和政府在基因组学领域的持续资助预计将在预测期内促进市场增长。近年来,二代测序价格大幅下降。由于基因组学领域的进步以及不同测序方法和策略的发展等因素,测序成本显着下降,推动了市场增长。
随着第二波COVID-19疫情的爆发,拉丁美洲国家的确诊病例不断增加。目前,巴西正在迅速增加抗击新冠病毒的临床项目。人们越来越关注基因组测序和测试。例如,2020 年 7 月,淡水河谷理工学院 (ITV) 和 Fiocruz 宣布,他们计划对 Sars-CoV-2 进行最广泛的基因组测序研究。淡水河谷在这项研究上投资了 240 万巴西雷亚尔。从长远来看,此类举措将促进南美洲和中美洲测序试剂市场的增长。
南美洲和中美洲测序试剂市场按技术分为二代测序、桑格测序和三代测序。下一代测序细分市场在 2020 年占据最大市场份额。然而,预计桑格测序细分市场在预测期内的复合年增长率最高。
南美洲和中美洲测序试剂市场按试剂类型分为对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型。测序试剂盒细分市场在 2020 年占据最大市场份额,而文库试剂盒细分市场预计在预测期内将实现最高的复合年增长率。
南方中美洲测序试剂市场按应用细分为农业基因组学和法医学、临床研究、肿瘤学、生殖健康和其他应用。肿瘤学领域在 2020 年占据最大的市场份额。然而,预计临床研究领域在预测期内的市场复合年增长率最高。
基于最终用户方面,南美洲和中美洲测序试剂市场分为医院和诊所、研究机构、制药和生物技术公司以及其他最终用户。研究机构细分市场在 2020 年占据了最大的市场份额。此外,预计该细分市场在预测期内的复合年增长率最高。
一些与本报告有关的南美洲和中美洲测序试剂市场相关的主要和次要来源是美国临床肿瘤学会 (ASCO)、美国人类基因组学学会 (ASCG)和国际原子能机构(IAEA)。
Strategic insights for South and Central America Sequencing Reagents involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 342.80 Million |
Market Size by 2028 | US$ 737.60 Million |
Global CAGR (2021 - 2028) | 11.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 技术
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Sequencing Reagents refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Sequencing Reagents Market is valued at US$ 342.80 Million in 2021, it is projected to reach US$ 737.60 Million by 2028.
As per our report South and Central America Sequencing Reagents Market, the market size is valued at US$ 342.80 Million in 2021, projecting it to reach US$ 737.60 Million by 2028. This translates to a CAGR of approximately 11.6% during the forecast period.
The South and Central America Sequencing Reagents Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Sequencing Reagents Market report:
The South and Central America Sequencing Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Sequencing Reagents Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Sequencing Reagents Market value chain can benefit from the information contained in a comprehensive market report.